논문KCI 등재
Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct- acting antiviral therapy: A multicenter study for chronic hepatitis C”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (7)
관련 논문AI추천
Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Jae Young Jang, Seung Up Kim, Tom Ryu, Young Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Metabolic dysfunction in patients following DAAinduced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu, Yu-Ping Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Advancing metabolic risk profiling in chronic hepatitis B: Reply to correspondence on “Metabolic health in antiviral era of chronic hepatitis B”Jia-Horng Kao, Shang-Chin Huang대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors: Editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”Lung-Yi Mak, Rex Wan-Hin Hui대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis CHong Soo Kim, Jae Young Jang, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Seung Up Kim, Soung Won Jeong, Tom Ryu, Young Chang, Young Seok Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial 2 on “Impacts of metabol ic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues”Mindie H. Nguyen, Rui Huang대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133